MedPath

Deep Learning-based Classification and Prediction of Radiation Dermatitis in Head and Neck Patients

Recruiting
Conditions
Head and Neck Cancer
Radiation Dermatitis
Registration Number
NCT05607225
Lead Sponsor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Brief Summary

to develop a deep learning-based model to grade the severity of radiation dermatitis (RD) and predict the severity of radiation dermatitis in patients with head and neck cancer undergoing radiotherapy, so as to provide support for doctors' diagnosis and prediction.

Detailed Description

1. Image acquisition The images of the neck area were collected from the enrolled patients one week before and every week during radiotherapy. The photographs were taken from three angles (front, left and right oblique) of the neck area.

2. Grading evaluation Each image was individually graded by three experienced radiotherapy experts according to the RD criteria of RTOG

3. Data analysis Construct a dermatitis grading model basing on deep learning. Evaluate the performance of model using accuracy, precision, recall, F1-measure, dice value.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
300
Inclusion Criteria
  • Age ≥ 18 years old.
  • Histologically or cytologically confirmed head and neck carcinoma confirmed by pathology.
  • Receive radical radiotherapy including neck area
  • Informed consent.
Exclusion Criteria
  • unable to cooperate with image acquisition

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
PrecisionJuly 1, 2022 to June 30, 2025

The proportion of positive samples in the positive prediction result

ROC curveJuly 1, 2022 to June 30, 2025
AccuracyJuly 1, 2022 to June 30, 2025

Evaluate the rate of deep learning based rating model in accordance with experts' assessment.

F1-measureJuly 1, 2022 to June 30, 2025

The harmonic average of precision and recall

RecallJuly 1, 2022 to June 30, 2025

The proportion of positive samples that were predicted to be positive

Secondary Outcome Measures
NameTimeMethod
dice valueJuly 1, 2022 to June 30, 2025

Ratio of overlap and distance between artificial and automatic neck segmentation regions

Trial Locations

Locations (2)

Shenzhen Cancer Hospital, Chinese Academy of Medical Sciences

🇨🇳

Shenzhen, Guangdong, China

Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College

🇨🇳

Beijing, China

© Copyright 2025. All Rights Reserved by MedPath